TMEM62 inhibitors belong to a class of chemicals that specifically target the transmembrane protein 62 (TMEM62), which plays a role in various cellular processes. TMEM62, as its name suggests, is embedded within the lipid bilayer of cells, spanning the membrane with multiple domains that interact with the intracellular environment and the extracellular space. The inhibitors designed to affect TMEM62 typically work by binding to the protein and altering its normal function. This interaction can lead to changes in the protein's configuration, preventing it from carrying out its biological role effectively. TMEM62 inhibitors are complex molecules that can be tailored to fit the unique structural features of the protein, engaging with it through a variety of non-covalent interactions such as hydrogen bonding, hydrophobic effects, and van der Waals forces. The precision of these interactions is crucial, as it determines the specificity and efficacy of an inhibitor.
The development of TMEM62 inhibitors requires a deep understanding of the protein's structure and function. The structure of TMEM62 is typically elucidated through techniques like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, which provide a high-resolution image of the protein at the atomic level. These images reveal the contours and charge distributions across the protein's surface, which are essential for designing inhibitors that can snugly fit and modulate TMEM62's activity. In terms of function, TMEM62 is implicated in a variety of cellular pathways, and the disruption of its activity by inhibitors can lead to a cascade of effects within the cell. Researchers study these effects using a combination of biochemical assays, cellular studies, and sometimes whole-organism models. By understanding how TMEM62 interacts with other cellular components and how its inhibition alters cellular function, scientists can design more effective inhibitors that are fine-tuned to the protein's unique characteristics.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $175.00 $700.00 | 9 | |
PF-4708671 is a selective inhibitor of the S6K1 kinase, downstream of mTOR, and its inhibition can lead to reduced protein synthesis and autophagy. This could indirectly affect the function of TMEM62. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $65.00 $162.00 $650.00 $2550.00 | 109 | |
Concanamycin A is a specific inhibitor of V-ATPase, like Bafilomycin A1, and it inhibits acidification of lysosomes, thus affecting autophagy. TMEM62's function in autophagy could be decreased by this action. |